Table 3.
Characteristic | Mode of Nutrition
|
Univariate P Value | |
---|---|---|---|
Parenteral (n=34) | Enteral (n=23) | ||
Age, years, median (IQR) | 3.1 (1.6–6.6) | 8.9 (3.7–14.6) | .001 |
Gender (% Male) | 61.8 | 26.1 | .014 |
Primary Motility Disorder (%) | 29.4 | 26.1 | .99 |
Ethanol locks (%) | 17.6 | 0 | .07 |
Lengthening Procedure (%) | 20.6 | 4.3 | .13 |
Presence of ICV (%) | 17.6 | 39.1 | .12 |
PPI/H2 Blocker Treatment (%) | 79.4 | 73.9 | .75 |
ALT, unit/L, median (IQR) | 46.0 (23.5 – 110.5) | 28.0 (18.5 – 45.5) | .013 |
Total Bilirubin, mg/dL, median (IQR) | 0.30 (0.20 – 0.80) | 0.35 (0.20–0.58) | .64 |
Direct Bilirubin, mg/dL, median (IQR) | 0.10 (0.10 – 0.20) | 0.10 (0.10 – 0.25) | .15 |
Albumin, g/dL, median (IQR) | 3.70 (3.13 – 4.00) | 4.10 (3.60 – 4.50) | .06 |
P values are significant at n=0.05
PN= parenteral nutrition, ICV= ileocecal valve, PPI = proton pump inhibitor, H2= histamine 2, ALT= alanine transaminase